Using artificial intelligence in MS clinical trials
Автор: VJNeurology
Загружено: 2021-10-25
Просмотров: 432
Описание: Carmen Tur, MD, PhD, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain, outlines the potential applications of artificial intelligence (AI) in multiple sclerosis (MS) clinical trials. These include patient selection, enabling the identification of patients most likely to benefit from a given treatment, and novel outcome measure discovery. The use of AI is in its infancy in MS and while its potential to improve trial conduction and outcomes is apparent, much more research is needed. This interview took place at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress 2021.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![Chat GPT Vs. Multiple Sclerosis [Can AI Replace Doctors?]](https://imager.clipsaver.ru/M_E3M21qPYQ/max.jpg)
